Publications A Systematic Review On Immune Checkpoint Inhibitor-Associated Enterocolitis Citation Ma C, MacDonald JK, Nguyen TM, Vande Casteele N, Linggi B, Lefevre P, Wang Y, Feagan BG, Jairath V. Pharmacological Interventions for the Prevention and Treatment of Immune Checkpoint Inhibitor-Associated Enterocolitis: A Systematic Review. Dig Dis Sci. 2022 Apr;67(4):1128-1155. doi: 10.1007/s10620-021-06948-w. Epub 2021 Mar 26. PMID: 33770330. Abstract Background: Patients treated with immune checkpoint inhibitors (ICIs) may develop ICI-associated enterocolitis, for which there is no approved treatment. Aims: We aimed to systematically review the efficacy and safety of medical interventions for the prevention and treatment of ICI-associated enterocolitis. Tags Adverse Effects, Checkpoint inhibitor, Cytotoxic T lymphocyte-associated protein, Enterocolitis, Immune Checkpoint Inhibitors, Immunosuppressive Agents, immunotherapy, Infliximab, Ipilimumab, Programmed cell death receptor, therapeutic use Read More